Researchers have identified a biomarker in human platelets that tracks the extent of depression – the review of new study by BIOMEDICA CRO
The new study, “A Novel Peripheral Biomarker for Depression and Antidepressant Response,” published in Molecular Psychiatry, has identified the cellular biomarker for translocation of Gs alpha from lipid rafts. The biomarker can be identified through a blood test.
Currently, patients and their physicians have to wait several weeks, sometimes months, to determine if antidepressants are working, and when it is determined they aren’t working, different therapies are tried.
The researchers hypothesize they will be able to use this blood test to determine if antidepressant therapies are working, perhaps as soon as one week after beginning treatment. “Because platelets turn over in one week, you would see a change in people who were going to get better. You’d be able to see the biomarker that should presage successful treatment,” Rasenick said.
Please follow the link for more info.
BIOMEDICA CRO is proud to participate in research on new biomarkers and developing new tests. We are ready to collect high-quality human biospecimens to provide scientists with all needed samples and associated data for their studies. Please email us to start our collaboration: office@biomedica-cro.com or visit our page with relevant biospecimens options.
